Trader2004 Posted - 2 weeks ago

@Trade_Bot Check out CLYM I go mostly by hires...At lows the Executive Director Clinical Development of $HZNP and $ALXN was hired in August...RA Capital owns 37%...

Trader2004 Posted - 1 month ago

@yus37 Few others i'm long because of recent hires...3 ex $HZNP execs joined SGMT team last 18 mos....$TRML is self explanatory when $SGEN Ceo takes the chairman pos after 40 b buyout...

NVDAMillionaire Posted - 3 months ago

$HZNP Horizon Therapeutics plc: A Diversified Biopharma Powerhouse Poised for Continued Growth http://beyondspx.com/2024/08/05/horizon-therapeutics-plc-a-diversified-biopharma-powerhouse-poised-for-continued-growth/

QuiverQuant Posted - 3 months ago

CONGRESSIONAL TRADING: Representative Greg Landsman disclosed a sale of $1,001 - $15,000 of $HZNP on 2024-08-14.

ponderevo Posted - 3 months ago

$HZNP for folks who prefer landscape mode, here’s the whole building. Fancy-shmancy and a prime location, too, steeped in history.

ponderevo Posted - 3 months ago

$HZNP posting for old time’s sake — this one was good to me. Dublin headquarters.

BluntForceOptions Posted - 04/26/24

$SLRN Food for thought: I don't invest in co's based solely on T/O speculation, but considering Acelyrin's laughably low 418M MC & -307M EV, it's clear there's a unique opportunity for those looking to expand. With a BOD rich in M&A experience, it's definitely not out of the question to think major players who missed out on $HZNP to $AMGN could be taking a serious look. Acelyrin boasts robust, late-stage programs and a promising anti-cKIT monoclonal antibody (w/a lead indication for Chronic Urticaria (CU), a market expected to grow to greater than $5.8B globally by 2030), that could be exactly what co's like $SNY need to bolster their portfolios. IMO, the combo of Acelyrin's advanced PL and obvious undervaluation forms a rare alignment that could spark interest from larger bios seeking significant, strategic additions at a value-driven entry point. Time will tell, but in the meantime, I remain extremely bullish and anticipating a strong reversal in the near future. Blessings to all.

Ycapital Posted - 02/23/24

$ATVI $HZNP $VMW

Oppie001 Posted - 8 months ago

$IOVA Yep! Seen this movie before $HZNP. Pop heavy

JthanP Posted - 8 months ago

$IOVA this stock was an oldie but goodie...owned this 2 years ago, and let me say, this reminds me of another $HZNP I had. They may try to shake the apples from the tree....but just have conviction. Congrats to the Bulls, and GLTA!

hashtagzee Posted - 9 months ago

$AUPH $HZNP Remember this PR by a former Aurinia BOD member and then CEO of Horizon Tim Walbert? https://www.investors.com/news/technology/hznp-stock-rockets-as-it-considers-potential-bids-from-three-big-pharma-stalwarts/ At this stage of the game, for a single asset company you either have offers or you have none. If they really had any genuine interest, they would go this route and generate some bidding action. My guess is they’ve got nothing and if that is the case, PG must be sacked for his dismal GIA performance thus far.

BullMarketStocks Posted - 10 months ago

@howhardgerrard87 I bought into both $ardx and $calt Jan of last year after $hznp got bought out, also deployed that cash into $agio as another smaller bio bet.

bdubs84 Posted - 10 months ago

$CYTK the betaville rumor on Amgen is garbage…they are literally the worst pump and dump shop out there. Amgen closed $HZNP in October and has nowhere near the balance sheet to support a $10B+ acquisition after shelling out $28B for $HZNP. Most likely suitor based on balance sheet alone would be $JNJ as they have the cash to do a deal this big and have already been mentioned as one of the three likely bidders per WSJ.

Coastalcool Posted - 10 months ago

$AMAM $HZNP $TCBP $TPST

FBP Posted - 10 months ago

$BCRX solid prelim ER but bigger q is wtf is the market going to valuations? Cuz it seems very GIA atm and even at that pretty cheap. Could see this be a horizon $HZNP some day

Coastalcool Posted - 10 months ago

$TCBP A Look at recent history of some battered bios such as $AMAM , $TPST & others will tell you that only the ones who persevered blocked the noise took it home. Some great names such as $HZNP were down to sub $ but thrived to become a multi Billion$ bios. The game is on for me & others. Kuddos to them if they took their winning hands & left. As for the rest of us its just noise right now.

muldoon92 Posted - 12/23/23

$AMGN one of my top plays for 2024. Look at the monthly bars converging. Retest of all time highs likely coming soon with: *bullish optimism surrounding biotech with $XBI turnaround *JPM24 usually yielding more M&A moves *obesity data readouts *hopefully positive updates on $HZNP integration *3% dividend yield to boot What’s not to love here? Wish we could get a more attractive entry price but will likely acquire 25-50% of desired size initially and rest on any pullbacks in new year…

Quantumup Posted - 11 months ago

BMO⬆️ $AMGN OP/$326: A budding oral/inj pipe gives invs the opp2play obesity w/out the same premium as peers like $LLY (still🩷); closure of $HZNP deal takes step towards replacing rev lost2base biz erosion; a rich cat path into '24 for its pipe could drive add'l multi expansion.

kimberlyanoerrth Posted - 11 months ago

$HZNP Who thinks this is real?! I saw is on another board yesterday and it seems scary! https://www.youtube.com/watch?v=ds-TrAnK2uQ

Coastalcool Posted - 11/27/23

@IDEXTOMOON But I am alive &well. Every t10% drop, I get 10% energized & focused. I will be your night mare. I bought $HZNP 15 years ago was still in it when $AMGN bought it at $127/share.

digitalcori Posted - 1 year ago

📈💼 Tudor Investment Corp's buys surge! From biotech to tech giants, Jones' moves reveal confidence! Explore the $1.43B boost & the new additions reshaping the portfolio! 💹🚀 #InvestmentMoves #TudorInvestment Q3 2023 portfolio, worth $9.73 Billion and containing 2226 stocks Top holding: $ATVI, $SGEN, $SPLK, $HZNP, and $SPY https://tickertracker.io/articles/pyo82q68v0-paul-tudor-jones-reveals-9-73-billion-portfolio-holdings-for-q3-2023-insights-into-investment-strategy-and-decision-making

TrendyChart Posted - 10/26/23

Upcoming Earnings Report: $HZNP Horizon Therapeutics will be reporting on 11/06/2023 at 7:00AM | Will earnings surpass or fall short of projections?

Coastalcool Posted - 10/24/23

$QNRX is proudly joining the list of Rare Genetic Diseases $SRPT , $HZNP etc. For the first time the Kids of NS could be kids. QRX003 as a srrine protesse inhibitor can work on other Rare/Genetic Skin Diseases as off label.

cctranscripts Posted - 1 year ago

Securities registration termination [Section 12(g)] https://www.conferencecalltranscripts.org/summary/?id=12618142 $HZNP

ChartMill Posted - 1 year ago

New 52 week highs for $HZNP, $SUZ, $MPLX, $NATI and $FAST https://www.chartmill.com/stock/stock-screener?f=p_pg10,v1_50b500,s_nh,exch_us&v=3&utm_source=New_52_week_high_today&utm_medium=stocktwits&utm_campaign=screen

WOLFSTREET Posted - 1 year ago

$HZNP Wow, this activist oldie really gets paid by the market to fund his stuff. He picked this up in mass when the markets brought the price down ??? around Q3-Q4 2022. By the time word got out, it recovered FAST! I think Soros himself may be the ultimate COMPASS.

UltraAlgo Posted - 1 year ago

$HZNP Awaiting Short Signal based off 5 signals, based on the 15 minute chart. Chart by 🚀 UltraAlgo https://i.redd.it/528jqinnu7tb1.png

tickeron Posted - 1 year ago

Maybe this is a good chance to make a profit? $HZNP in +0.07% Uptrend, rising for three consecutive days on October 5, 2023. View odds for this and other indicators: https://srnk.us/go/4885731

Coastalcool Posted - 1 year ago

$QNRX This company is the next $HZNP , just aquired by $AMGN for $129/share.See the similarities * They both address the umet needs of Rare/Genetic Orphan Diseases. * Both were granted IND for their assets. * Both are extremely vital to their perspective disease group. * They both have the Mega Pricing Power. $HZNP has raised its prices about 16x in the last 14 years. where $QNRX superceed $HZNP is the followings: * QRX04: going to Clincal in q1, 2024 for Epidermolysis Bolusa ( Rare Genetic Disease) * * QRX07: inline to go Clinical trial in 2024 for Scleroderma, a divestating & killer diease, Rare& Genetic disease. *** Off label use of QRX03 for all other Rare & Genetic diseases.

stockilluminati Posted - 1 year ago

$HZNP https://clinicaltrials.gov/study/NCT05831098 - trial update posted here!